Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Mernberger

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
The EMBO Journal|September 5, 2019
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responsesOleg Timofeev, Boris Klimovich, Jean Schneikert, et al.
The EMBO Journal|March 25, 2026
Author Correction: Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responsesOleg Timofeev, Boris Klimovich, Jean Schneikert, et al.
Cancer Research|September 3, 2020
Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and AgingOleg Timofeev, Lukas Koch, Constantin Niederau, et al.
International Journal of Cancer|June 8, 2026
Variant-Specific Landscape of Mutual Exclusivity Among BRAF, EGFR, and KRAS Oncogenes Reveals Overlap With Functionally Antagonistic Mutant PairsFreya Vaeyens, Jan-Patrick Hetzel, Khaldoon Abdullah, et al.
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Nature Chemical Biology|November 24, 2015
CRISPR-Cas9-based target validation for p53-reactivating model compoundsMichael Wanzel, Jonas B Vischedyk, Miriam P Gittler, et al.
Radiation Oncology (London, England)|July 3, 2024
Transcriptomic response of prostate cancer cells to carbon ion and photon irradiation with focus on androgen receptor and TP53 signalingJörg Hänze, Lilly M Mengen, Marco Mernberger, et al.
Nature Structural & Molecular Biology|January 9, 2025
DARPin-induced reactivation of p53 in HPV-positive cellsPhilipp Münick, Alexander Strubel, Dimitrios-Ilias Balourdas, et al.
Molecular Cancer|October 3, 2022
Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferaseNastasja Merle, Sabrina Elmshäuser, Florian Strassheimer, et al.
Oncotarget|April 9, 2019
Specific allelic variants of SNPs in the <i>MDM2</i> and <i>MDMX</i> genes are associated with earlier tumor onset and progression in Caucasian breast cancer patientsMarcus Bauer, Eva Johanna Kantelhardt, Thorsten Stiewe, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The EMBO Journal|September 5, 2019
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responsesOleg Timofeev, Boris Klimovich, Jean Schneikert, et al.
The EMBO Journal|March 25, 2026
Author Correction: Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responsesOleg Timofeev, Boris Klimovich, Jean Schneikert, et al.
Cancer Research|September 3, 2020
Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and AgingOleg Timofeev, Lukas Koch, Constantin Niederau, et al.
International Journal of Cancer|June 8, 2026
Variant-Specific Landscape of Mutual Exclusivity Among BRAF, EGFR, and KRAS Oncogenes Reveals Overlap With Functionally Antagonistic Mutant PairsFreya Vaeyens, Jan-Patrick Hetzel, Khaldoon Abdullah, et al.
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Nature Chemical Biology|November 24, 2015
CRISPR-Cas9-based target validation for p53-reactivating model compoundsMichael Wanzel, Jonas B Vischedyk, Miriam P Gittler, et al.
Radiation Oncology (London, England)|July 3, 2024
Transcriptomic response of prostate cancer cells to carbon ion and photon irradiation with focus on androgen receptor and TP53 signalingJörg Hänze, Lilly M Mengen, Marco Mernberger, et al.
Nature Structural & Molecular Biology|January 9, 2025
DARPin-induced reactivation of p53 in HPV-positive cellsPhilipp Münick, Alexander Strubel, Dimitrios-Ilias Balourdas, et al.
Molecular Cancer|October 3, 2022
Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferaseNastasja Merle, Sabrina Elmshäuser, Florian Strassheimer, et al.
Oncotarget|April 9, 2019
Specific allelic variants of SNPs in the <i>MDM2</i> and <i>MDMX</i> genes are associated with earlier tumor onset and progression in Caucasian breast cancer patientsMarcus Bauer, Eva Johanna Kantelhardt, Thorsten Stiewe, et al.
Pageof 4